The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocation.
about
The combination of a sphingosine kinase 2 inhibitor (ABC294640) and a Bcl-2 inhibitor (ABT-199) displays synergistic anti-myeloma effects in myeloma cells without a t(11;14) translocation.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The combination of a sphingosi ...... hout a t(11;14) translocation.
@en
The combination of a sphingosine kinase 2 inhibitor
@nl
type
label
The combination of a sphingosi ...... hout a t(11;14) translocation.
@en
The combination of a sphingosine kinase 2 inhibitor
@nl
prefLabel
The combination of a sphingosi ...... hout a t(11;14) translocation.
@en
The combination of a sphingosine kinase 2 inhibitor
@nl
P2860
P356
P1433
P1476
The combination of a sphingosi ...... thout a t(11;14) translocation
@en
P2093
Cristina Gasparetto
P2860
P356
10.1002/CAM4.1543
P407
P577
2018-05-15T00:00:00Z